Cisplatinum ototoxicity in children, long-term follow up

International Journal of Pediatric Otorhinolaryngology

Volumn 74, Issue 8, 2010, Pages 913-919

  Al Khatib, Talal ^a   Cohen, Natasha ^a   Carret, Anne Sophie ^b   Daniel, Sam ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Long term follow up; Ototoxicity; Pediatric otolaryngology; Platinum compound chemotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADOLESCENT; ARTICLE; AUDIOGRAPHY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEARING AID; HEARING IMPAIRMENT; HODGKIN DISEASE; HUMAN; INFANT; LONG TERM CARE; MALE; MEDICAL RECORD; NASOPHARYNX CARCINOMA; NONHODGKIN LYMPHOMA; OPTIC NERVE GLIOMA; OSTEOSARCOMA; OTOTOXICITY; PHARMACY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RETINOBLASTOMA; SCHOOL CHILD;

ADOLESCENT; AGE DISTRIBUTION; ANTINEOPLASTIC AGENTS; AUDIOMETRY; CHILD; CHILD, PRESCHOOL; CISPLATIN; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEARING LOSS, SENSORINEURAL; HUMANS; INCIDENCE; MALE; NEOPLASMS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TIME FACTORS;

EID: 77953912806     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2010.05.011     Document Type: Article

References (33)

1. Clark J.G. Uses and abuses of hearing loss classification. ASHA 1981, 23:493-500.
2. Lewis M.J., DuBois S.G., Fligor B., Li X., Goorin A., Grier H.E. Ototoxicity in children treated for osteosarcoma. Pediatr. Blood Cancer 2009, 52:387-391.
3. Schell M.J., McHaney V.A., Green A.A. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J. Clin. Oncol. 1989, 7:754-760.
4. Coradini P.P., Cigana L., Selistre S.G., Rosito L.S., Brunetto A.L. Ototoxicity from cisplatin therapy in childhood cancer. J. Pediatr. Hematol. Oncol. 2007, 29:355-360.
5. Dean J.B., Hayashi S.S., Albert C.M., King A.A., Karzon R., Hayashi R.J. Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens. J. Pediatr. Hematol. Oncol. 2008, 30:130-134.
6. Fouladi M., Gururangan S., Moghrabi A. Carboplatin-based primary chemotherapy for infants and young children with CNS tumors. Cancer 2009, 115:3243-3253.
7. Knight K.R., Kraemer D.F., Neuwelt E.A. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J. Clin. Oncol. 2005, 23:8588-8596.
8. Bertolini P., Lassalle M., Mercier G. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss. J. Pediatr. Hematol. Oncol. 2004, 26:649-655.
9. Stelmachowicz P.G., Pittman A.L., Hoover B.M., Lewis D.E., Moeller M.P. The importance of high-frequency audibility in the speech and language development of children with hearing loss. Arch. Otolaryngol. Head Neck Surg. 2004, 130:556-562.
10. Stelmachowicz P.G., Pittman A.L., Hoover B.M., Lewis D.E. Effect of stimulus bandwidth on the perception of/s/in normal- and hearing-impaired children and adults. J. Acoust. Soc. Am. 2001, 110:2183-2190.
11. Martinez-Cruz C.F., Poblano A., Conde-Reyes M.P. Cognitive performance of school children with unilateral sensorineural hearing loss. Arch. Med. Res. 2009, 40:374-379.
12. Culbertson J.L., Gilbert L.E. Children with unilateral sensorineural hearing loss: cognitive, academic, and social development. Ear Hear. 1986, 7:38-42.
13. Durrant SAFMTJWKRBSMFKSHVAMJMTJ. Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA 1994, 36:11.
14. Beck M.N., Balmer A., Dessing C., Pica A., Munier F. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma. J. Clin. Oncol. 2000, 18:2881-2887.
15. Yoshinaga-Itano C., Sedey A.L., Coulter D.K., Mehl A.L. Language of early- and later-identified children with hearing loss. Pediatrics 1998, 102:1161-1171.
16. Rybak L.P., Whitworth C.A., Mukherjea D., Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear. Res. 2007, 226:157-167.
17. van Ruijven M.W., de Groot J.C., Hendriksen F., Smoorenburg G.F. Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs. Hear. Res. 2005, 203:112-121.
18. Meech R.P., Campbell K.C., Hughes L.P., Rybak L.P. A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis. Hear. Res. 1998, 124:44-59.
19. Alam S.A., Ikeda K., Oshima T. Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea. Hear. Res. 2000, 141:28-38.
20. Liang F., Schulte B.A., Qu C., Hu W., Shen Z. Inhibition of the calcium- and voltage-dependent big conductance potassium channel ameliorates cisplatin-induced apoptosis in spiral ligament fibrocytes of the cochlea. Neuroscience 2005, 135:263-271.
21. Husain K., Scott R.B., Whitworth C., Somani S.M., Rybak L.P. Dose response of carboplatin-induced hearing loss in rats: antioxidant defense system. Hear. Res. 2001, 151:71-78.
22. Garcia-Ruiz C., Colell A., Mari M., Morales A., Fernandez-Checa J.C. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J. Biol. Chem. 1997, 272:11369-11377.
23. Li Y., Womer R.B., Silber J.H. Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose. Eur. J. Cancer 2004, 40:2445-2451.
24. Ruiz L., Gilden J., Jaffe N., Robertson R., Wang Y.M. Auditory function in pediatric osteosarcoma patients treated with multiple doses of cis-diamminedichloroplatinum(II). Cancer Res. 1989, 49:742-744.
25. Brock P.R., Bellman S.C., Yeomans E.C., Pinkerton C.R., Pritchard J. Cisplatin ototoxicity in children: a practical grading system. Med. Pediatr. Oncol. 1991, 19:295-300.
26. Ilveskoski I., Saarinen U.M., Wiklund T. Ototoxicity in children with malignant brain tumors treated with the " 8 in 1" chemotherapy protocol. Med. Pediatr. Oncol. 1996, 27:26-31.
27. Chen W.C., Jackson A., Budnick A.S. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer 2006, 106:820-829.
28. Walker D.A., Pillow J., Waters K.D., Keir E. Enhanced cis-platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation. Med. Pediatr. Oncol. 1989, 17:48-52.
29. Boothroyd A. Room acoustics and speech perception. Semin. Hear. 2002, 18.
30. Horwitz A.R., Dubno J.R., Ahlstrom J.B. Recognition of low-pass-filtered consonants in noise with normal and impaired high-frequency hearing. J. Acoust. Soc. Am. 2002, 111:409-416.
31. Eisenberg L.S., Shannon R.V., Martinez A.S., Wygonski J., Boothroyd A. Speech recognition with reduced spectral cues as a function of age. J. Acoust. Soc. Am. 2000, 107:2704-2710.
32. Bess F.H., Dodd-Murphy J., Parker R.A. Children with minimal sensorineural hearing loss: prevalence, educational performance, and functional status. Ear Hear. 1998, 19:339-354.
33. Furstenberg K., Doyal G. The relationship between emotional-behavioral functioning and personal characteristics on performance outcomes of hearing impaired students. Am. Ann. Deaf. 1994, 139:410-414.